#USA #Dallas #Unifeye Vision #Mark Garvin #Martin Rash

Unifeye Vision Partners Welcomes Mark Garvin as New CEO

Unifeye Vision Partners (UVP), an influential player in the ophthalmology sector operating numerous ambulatory surgery centers (ASCs), has confirmed the appointment of Mark Garvin as its new Chief Executive Officer (CEO). This transition marks a significant leadership change as Garvin takes over from Martin Rash, who has made vital contributions to UVP and now steps into the role of Executive Chairman of the Board of Directors.

Garvin brings over three decades of healthcare expertise to UVP, most recently serving at Banner Health. He is particularly noted for his tenure of nearly 20 years at United Surgical Partners International (USPI), where he was instrumental in navigating the company through pivotal growth phases. Under his leadership, USPI solidified its position as one of the largest ASC operators in the country, leveraging both organic and inorganic growth strategies.

Expressing his enthusiasm for the new role, Garvin stated, "It's an honor to join UVP and work alongside physicians and my teammates to expand patient access, improve overall experiences, and grow our integrated ASC and clinic presence in both existing and new markets. Our focus will be on delivering measurable outcomes and operational excellence, while enhancing talent growth and ensuring a distinctive patient experience that creates value for all stakeholders."

Chris Graber, a partner at Waud Capital Partners—UVP's founding investor—expressed confidence in Garvin’s leadership. He emphasized that the board welcomes Garvin at a crucial time for the company. Graber acknowledged Rash’s impactful leadership during a period of significant growth, attributing UVP's current strong market position to his guidance. In responding to the transition, Rash remarked, "I’m thrilled to welcome Mark to our team. His extensive career in supporting physician growth through ASCs and recruitment is invaluable, and I am confident he will lead UVP through its next phase of growth successfully."

Under Garvin's stewardship, UVP is poised to continue fostering the development of comprehensive eye care practices through ASC optimization and expansion, with a keen focus on physician recruitment and operational improvements. This aligns with the company's mission to enhance healthcare quality and accessibility in ambulatory settings.

About Unifeye Vision Partners

UVP is a physician-led organization specializing in the operation of ambulatory surgery centers, offering integrated practice management services focused on the ophthalmology field. With a network that currently encompasses 66 clinic locations and 19 ASCs, UVP strives to deliver comprehensive management and support to ophthalmology and optometry practices, as well as single-specialty eye surgery centers. More details about their mission and services can be found on their website at www.uvpeye.com.

About Waud Capital Partners

Waud Capital Partners is a private equity firm based in Chicago, operating for more than 30 years with a focus on growth-oriented investments. The firm collaborates with seasoned management teams to create industry-leading companies in healthcare and software technology. Since its establishment in 1993, Waud Capital has executed over 500 investments covering a range of platform companies and follow-on opportunities. For further details, visit www.waudcapital.com.